ArticlePharmaceuticals (Basel, Switzerland)2023

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration.

Sungyeun Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.